Drug lookup
Drug reference

Telenzepine

Antimuscarinic · Antiulcer Agent

AntimuscarinicAntiulcer Agent
CDSCO approvedSchedule H
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Telenzepine is an M1 muscarinic receptor antagonist, structurally an analog of pirenzepine, with higher potency and similar M1 selectivity. It acts as an inverse agonist, shifting muscarinic receptors to an inactive state to prevent acetylcholine binding and subsequent effects like inositol trisphosphate (IP3) release and adenylyl cyclase inhibition. Telenzepine suppresses neural stimulation of gastric acid production by acting on M1 receptors located in intramural ganglia.

Indications

Acid-peptic diseasePeptic ulcer diseasePeptic ulcer disease (used in Europe, Japan, and Canada, not in the U.S.)

Dosing

Adult
In the doses usually used, atropine has minimal stimulant effects on the CNS, especially the parasympathetic medullary centers, and a slower, longer­ lasting sedative effect on the brain. Scopolamine has more marked central effects, producing drowsiness when given in recommended dosages and amnesia in sensitive individuals that may be mediated via the histamine H3 receptor.…

Contraindications

  • Rarely used today due to poor efficacy and significant side effects

Side effects

Common
XerostomiaLoss of visual accommodationPhotophobiaDifficulty in urinationSignificant and undesirable anticholinergic side effects
Serious
  • Blood disorders

Related guidelines

Other Antimuscarinic drugs

Ask House about Telenzepine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Katzung·Verified: 2026-05-13 · House clinical team